TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Orifarm Generics AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
52,212
|
43,830
|
48,403 |
| Financial expenses |
25
|
43
|
105 |
| Earnings before taxes |
1,021
|
1,146
|
1,162 |
| EBITDA |
914
|
767
|
1,206 |
| Total assets |
13,547
|
9,942
|
7,815 |
| Current assets |
12,943
|
9,429
|
7,305 |
| Current liabilities |
10,774
|
7,344
|
5,972 |
| Equity capital |
2,774
|
2,598
|
1,842 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
20.5%
|
26.1%
|
23.6% |
| Turnover per employee |
17,404
|
14,610
|
16,134 |
| Profit as a percentage of turnover |
2.0%
|
2.6%
|
2.4% |
| Return on assets (ROA) |
7.7%
|
12.0%
|
16.2% |
| Current ratio |
120.1%
|
128.4%
|
122.3% |
| Return on equity (ROE) |
36.8%
|
44.1%
|
63.1% |
| Change turnover |
8,254
|
-652
|
15,901 |
| Change turnover % |
19%
|
-1%
|
49% |
| Chg. No. of employees |
0
|
0
|
3 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.